Cytoplasmic and nuclear accumulation of antisense oligomers incubated as streptavidin delivery nanoparticles

Current Radiopharmaceuticals

Volumn 2, Issue 2, 2009, Pages 112-117

  Liu, Xinrong ^a   Wang, Yi ^a   Nakamura, Kayoko ^b   Liu, Guozheng ^a   Chen, Ling ^a   Dou, Shuping ^a   Rusckowski, Mary ^a   Hnatowich, Donald J ^a,b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antisense oligomer; mdr1; Nanoparticle; Nuclear migration; Streptavidin

Indexed keywords

MESSENGER RNA; NANOPARTICLE; OLIGOMER; RHODAMINE 123; STREPTAVIDIN;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CYTOPLASM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL; SKIN CARCINOMA;

EID: 77953769752     PISSN: 18744710     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874471010902020112     Document Type: Article

References (24)

1. Hnatowich, D.J.; Nakamura, K. The influence of chemical structure of DNA and other oligomer radiopharmaceuticals on tumor delivery. Curr. Opin. Mol. Ther., 2006, 8, 136-143.
2. Tung, C.H.; Stein, S. Preparation and applications of peptideoligonucleotide conjugates. Bioconjug. Chem., 2000, 11, 605-618.
3. Lee, H.J.; Partridge, W.M. Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo. Bioconjug. Chem., 2001,12, 995-999.
4. Lee, H.J.; Boado, R.J.; Braasch, D.A.; Corey, D.R.; Partridge, W.M. Imaging gene expression in the brain in vivo in a transgenic mouse model of Huntington's disease with an antisense radiopharmaceutical and drug-targeting technology. J. Nucl. Med., 2002, 43, 948-956.
5. Nakamura, K.; Wang, Y.; Liu, X.; Kubo, A.; Hnatowich, D.J. Addition of TAT, polyarginine and cholesterol carriers to mdr1 antisense DNA using streptavidin as linker [Abstract]. J. Nucl. Med. (Suppl), 2006, 47, 512P.
6. Wang, Y.; Nakamura, K.; Liu, X.; Kitamura, N.; Kubo, A.; Hnatowich, D.J. Simplified preparation via streptavidin of antisense oligomers/carriers nanoparticles showing improved cellular delivery in culture. Bioconjug. Chem., 2007, 18, 1338-1343.
7. Liu, X.; Wang, Y.; Nakamura, K.; Kubo, A.; Hnatowich, D.J. Cell studies of a three-component antisense MORF/tat/Herceptin nanoparticle designed for improved tumor delivery. Cancer Gene Ther., 2008, 15, 126-132.
8. Nakamura, K.; Wang, Y.; Liu, X.; Kitamura, N.; Kubo, A.; Hnatowich, D.J. Cell culture and xengrafted animal studies of radiolabeled antisense DNA/carrier constructs using streptavidin as linker. J. Nucl. Med., 2007, 48, 1845-1852.
9. Wang, Y.; Liu, X.; Nakamura, K.; Chen, L.; Rusckowski, M.; Hnatowich, D.J. The biodistribution in tumored mice of 99mTc labeled antisense MORF/carrier streptavidin nanoparticles. J. Nucl. Med., 2008, 49(Suppl.), 51-52.
10. Liu, X.; Wang, Y.; Nakamura, K.; Chen, L.; Kawauchi, S.; Rusckowski, M.; Hnatowich, D.J. Successful radiotherapy of tumor cells using a three-component streptavidin delivery nanoparticle and 111In. J. Nucl. Med., (in press).
11. Jensen, K.D.; Nori, A.; Tijerina, M.; Kopeckova, P.; Kopecek, J. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules. J. Control Release, 2003, 87, 89-105.
12. Zhang, Y.M.; Liu, C.B.; Liu, N.; Ferro, F.G.; He, J.; Rusckowski, M.; Hnatowich, D.J. Electrostatic binding with tat and other cationic peptides increases cell accumulation of 99mTc-antisense DNAs without entrapment. Mol. Imaging Biol., 2003, 5, 240-247.
13. Liu, X.; Nakamura, K.; Wang, Y.; Wang, Y.; Liu, G.; He, J.; Ding, H.; Lu, P.; Rusckowski, M.; Kubo, A.; Hnatowich, D.J. Initial mechanistic studies of antisense targeting in cells. J. Nucl. Med., 2006,47, 360-368.
14. Nakamura, K.; Kubo, A.; Hnatowich, D.J. Antisense targeting of pglycoprotein expression in tissue culture. J. Nucl. Med., 2005, 46, 509-13.
15. Nakamura K.; Fan C.; Liu G.; Gupta S.; He J.; Dou S.; Kubo A.; Rusckowski M.; Hnatowich D.J. Evidence of antisense tumor targeting in mice. Bioconjug. Chem., 2004, 15, 1475-1480.
16. Vives, E.; Richard, J.P.; Rispal, C.; LeBleu, B. TAT peptide internalization: seeking the mechanism of entry. Curr. Protein Pept. Sci., 2003, 4, 125-132.
17. Wang, Y.; Liu, X.; Hnatowich, D.J. An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with 99mTc at room temperature. Nat. Protoc., 2007, 2, 972-978.
18. Alahari, S.K.; Delong, R.; Fisher, M.H.; Dean, N.M.; Viliet, P.; Juliano, R.L. Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression. J. Pharm. Exp. Therapeut., 1998, 286, 419-428.
19. Liu, X.; Wang, Y.; Nakamura, K.; Liu, G.; Dou, S.; Kubo, A.; Rusckowski, M.; Hnatowich, D.J. Optical antisense imaging of tumor with fluorescent DNA duplexes. Bioconjug. Chem., 2007, 18, 1905-1911.
20. Shi, F.; Hoekstra, D. Effective intracellular delivery of oligonucleotides in order to make sense of antisense. J. Control Release, 2004,97, 189-209.
21. Prow, T.; Smith, J.N.; Grebe, R.; Salazar, J.H.; Wang, N., Kotov, N.; Lutty, G.; Leary, J. Construction, gene delivery, and expression of DNA tethered nanoparticles. Mol. Vis., 2006, 12, 606-615.
22. Nakamura, K.; Wang, Y.; Liu, X.; Kubo, A.; Hnatowich, D.J. Influence of two transfectors on delivery of 99mTc antisense DNA in tumor-bearing mice. Mol. Imaging Biol., 2006, 8, 188-192.
23. Nakamura, K.; Wang, Y.; Liu, X.; Kubo, A.; Hnatowich, D.J. Cationic transfectors increase accumulation in cultured tumor cells of radiolabeled antisense DNAs without entrapment. Cancer Biother. Radiopharm., 2007, 22, 629-635.
24. Hatta, T.; Takai, K.; Nakada, S.; Yokota, T.; Takaku, H. Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleotides in clone 76 cells. Biochim. Biophy. Res. Comm., 1997,232, 545-549.